Deletion of myeloid‐specific METTL3, which is the catalytic component of methyltransferase complex, reduces the translation of SPRED2 which ultimately increases the activation of STAT3 and NF‐kB via the ERK pathway promoting increased tumor growth and metastasis.128. The gene discussed is NFKB1; the disease is neoplasm.